Articles From: Bright Horizons Family Solutions Announces Date of Third Quarter 2014 Earnings Release and Conference Call to Bristol-Myers Squibb and MD Anderson Cancer Center Announce Novel Research Collaboration in Immuno-Oncology Focused on Leukemia and Hematologic Malignancies


WATERTOWN, Mass.
Sign-up for Bright Horizons Family Solutions Announces Pricing of Secondary Offering investment picks
2014/9/23
Aerie to Donate 100% of Sales From Limited-Edition Bright Pink Charley™ Bra to Bright Pink CHICAGO , Sept.
Sign-up for Bright Pink® Teams Up With Aerie® By American Eagle Outfitters For The 2014 Show Your Support Campaign Focused On Breast Health Awareness For Young Women investment picks
Brightcove Inc. (NASDAQ: BCOV), a leading global provider of cloud services for video, today announced it will report its third quarter results for the fiscal period ended September 30, 2014, after the U.S. financial markets close on Thursday, October 30, 2014.
Sign-up for Brightcove Announces Date of Third Quarter 2014 Conference Call and Webcast investment picks
Brightcove Inc .
Sign-up for Brightcove Announces Financial Results for Third Quarter 2014 investment picks
Brightcove Inc .
Sign-up for Brightcove Appoints Kevin Rhodes as Chief Financial Officer investment picks
AstraZeneca (NYSE:AZN) today confirmed that the American Heart Association (AHA) and American College of Cardiology (ACC) have updated the guideline for the management of patients with non–ST-elevation acute coronary syndromes (NSTE-ACS). The guideline supports differentiation among currently available P2Y 12 inhibitors, including ticagrelor, clopidogrel, and prasugrel, for these patients.
Sign-up for BRILINTA Preferred Over Clopidogrel in 2014 AHA/ACC Guideline for the Management of Non–ST-Elevation Acute Coronary Syndromes investment picks
2014/10/14
New collaboration available now at select Urban Outfitters, Teva.com and Woolrich.com GOLETA, Calif.
Sign-up for Bringing Back #SocksandSandals: Teva Partners with Woolrich investment picks
2014/9/30
http://media.marketwire.com/attachments/201012/17558_MOENLogo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1148227&ProfileId=051205&sourceType=1 NORTH OLMSTED, OH --
Sign-up for Bringing Faucets to Life at Sketchfest: Moen's Global Design Team Finds Inspiration in Italy investment picks
2014/11/20
BRINK, a new digital news hub that informs global business leaders, policy-makers, and journalists by providing actionable insights and ideas about current and emerging risks has launched.
Sign-up for BRINK Launches Global Risks & Innovation Video investment picks
2014/11/11
BRINK, a new digital news hub that informs global business leaders, policy-makers, and journalists by providing actionable insights and ideas about current and emerging risks, launched today.
Sign-up for BRINK, a Digital News Hub on Global Risk Issues, Launches Today investment picks
Reaffirms 2015 and 2016 Financial Targets RICHMOND, Va.
Sign-up for Brink's Announces Organizational Changes investment picks
RICHMOND, Va.
Sign-up for Brink's Declares Quarterly Dividend investment picks
Non-GAAP EPS $.19 vs $.69; GAAP EPS $.38 vs $.61 Latin America Results Hurt by Currency, Organic Profit Decline and Chile Theft Loss Management Reduces 2014 Outlook, Continues to Expect Strong Profit Growth in 2015 and 2016 RICHMOND, Va.
Sign-up for Brink's Reports Third-Quarter Results investment picks
RICHMOND, Va.
Sign-up for Brink's Sells Minority Interest in CIT Business in Peru investment picks
The Brink's Company (BCO) said it is overhauling the way it does business to ensure it is in the right position to achieve its future financial goals.
Sign-up for Brink's to overhaul business to meet 2015-16 margin targets investment picks
RICHMOND, Va.
Sign-up for Brink's To Restructure Netherlands Operations investment picks
DALLAS , Oct.
Sign-up for Brinker International Board Declares Common Dividend investment picks
By Jonathan D.
Sign-up for Bristol-Myers drops Hepatitis C dual regimen in U.S. investment picks
Bristol-Myers Squibb (BMY) reported Friday third-quarter net profit that rose to $721 million, or 43 cents a share, from $692 million, or 42 cents a share, in the year-earlier period.
Sign-up for Bristol-Myers profit slips, but tops expectations investment picks
Bristol-Myers Squibb Company (NYSE:BMY) and Five Prime Therapeutics, Inc. (Nasdaq:FPRX) today announced that they have entered into an exclusive clinical collaboration agreement to evaluate the safety, tolerability and preliminary efficacy of combining Opdivo (nivolumab), Bristol-Myers Squibb’s investigational PD-1 (programmed death-1) immune checkpoint inhibitor, with FPA008, Five Prime’s monoclonal antibody that inhibits colony stimulating factor-1 receptor (CSF1R). The Phase 1a/1b study will evaluate the combination of Opdivo and FPA008 as a potential treatment option for patients with non-small cell lung cancer (NSCLC), melanoma, head and neck cancer, pancreatic cancer, colorectal cancer and malignant glioma.
Sign-up for Bristol-Myers Squibb and Five Prime Therapeutics Announce Exclusive Clinical Collaboration to Evaluate the Combination of Investigational Immunotherapies Opdivo (nivolumab) and FPA008 in Six Tumor Types investment picks
Bristol-Myers Squibb Company (NYSE:BMY) and Lonza today announced a multi-year expansion of their existing biologics manufacturing agreement.
Sign-up for Bristol-Myers Squibb and Lonza Expand Manufacturing Agreement investment picks
Bristol-Myers Squibb Company (NYSE:BMY) and The University of Texas MD Anderson Cancer Center today announced a novel clinical research collaboration to evaluate multiple immunotherapies, including Opdivo (nivolumab), Yervoy (ipilimumab) and three early-stage clinical immuno-oncology assets from Bristol-Myers Squibb, as potential treatment options for acute and chronic leukemia as well as other hematologic malignancies.
Sign-up for Bristol-Myers Squibb and MD Anderson Cancer Center Announce Novel Research Collaboration in Immuno-Oncology Focused on Leukemia and Hematologic Malignancies investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Bright Horizons Family Solutions Announces Date of Third Quarter 2014 Earnings Release and Conference Call to Bristol-Myers Squibb and MD Anderson Cancer Center Announce Novel Research Collaboration in Immuno-Oncology Focused on Leukemia and Hematologic Malignancies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent